What is exosome therapy?
Exosome therapy is a treatment that applies or injects particles released by stem cells, instead of the cells themselves. An exosome is a few hundred times smaller than a cell, wrapped in a membrane and unable to copy itself.[3]
What clinics sell as "exosomes" is usually the liquid that stem cells were grown in, filtered or purified to some degree.[3][4] One vial can be close to a protein soup; another can be a cleaner preparation. The label rarely tells you which.
Because there are no living cells, there is no harvest from your body. The product is made in advance from donor cells.[4]
How it is given
Face and scalp
Spread over the skin straight after microneedling or laser, or injected into the scalp with fine needles.[7] A session takes under an hour, and the usual after-effect is redness for a day or two.[8]
Joints
A single injection into the joint.[9]
IV drip
Sold for anti-aging and recovery. Only tested in trials for severe lung illness.[10]
What it is sold for
The evidence is thin and mostly cosmetic
Exosomes vs PRP
For the face, they came out even. In the one blinded head-to-head trial, each given with microneedling, both improved wrinkles, colour and texture by the same amount, and skin samples showed the same collagen gain on both sides.[13]
For hair, no trial has compared them directly. Indirect comparisons put PRP slightly ahead.[14]
The practical difference is the source. PRP is made from your own blood in the clinic, in front of you. An exosome vial comes from a donor and a lab you usually cannot check.[4][13] PRP vs stem cells
Side effects come mostly from injecting it
On the skin after microneedling, the reported side effects are redness and mild irritation.[8] Injected, published cases include lumps under the skin with permanent scarring,[15] tissue death in both cheeks,[16] and an allergic reaction after a scalp injection.[17] In 2019 the FDA warned the public after serious reactions in patients given unapproved exosome products.[1]
Is exosome therapy FDA approved?
No. No exosome product is approved by the FDA or any other regulator, for any use.[1]
United States. No exosome product is approved. Clinics may only use one inside an authorised clinical trial.[1]
Malaysia. Exosomes fall outside the cell therapy rules, which is not the same as permission. The product still needs another legal route.[18]
Mexico. No rule written for exosomes. COFEPRIS has said stem cell treatments lack authorisation.[19]
Questions to ask a clinic
- What cells were the exosomes made from, and which lab made them?
- Can I see the certificate for this batch, including sterility?
- The label gives a particle count. How much protein is in the vial?
- Is it applied to the skin or injected?
- Is it sold as a stem cell treatment? There are no living cells in it.
Sources
19 references
- U.S. Food and Drug Administration. Public safety notification on exosome products, 2019. Link
- Stack ER, et al. Clinical advances in exosome-based therapies for aesthetic medicine: a systematic review and meta-analysis. Aesthetic Surgery Journal, 2026. Link
- Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023). Journal of Extracellular Vesicles, 2024. Link
- Asadpour A, et al. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles and exosomes. Stem Cell Research & Therapy, 2023. Link
- Gupta D, et al. Dosing extracellular vesicles. Advanced Drug Delivery Reviews, 2021. Link
- Witwer KW, et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. Journal of Extracellular Vesicles, 2019. Link
- Park GH, et al. Efficacy of combined treatment with human adipose tissue stem cell-derived exosome-containing solution and microneedling. Journal of Cosmetic Dermatology, 2023. Link
- Jafarzadeh A, et al. Effectiveness of regenerative medicine for skin lightening and rejuvenation: a systematic review of extracellular vesicles and conditioned media. Stem Cell Research & Therapy, 2025. Link
- Bolandnazar NS, et al. Safety and efficacy of placental mesenchymal stromal cells-derived extracellular vesicles in knee osteoarthritis. BMC Musculoskeletal Disorders, 2024. Link
- Lightner AL, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19. Chest, 2023. Link
- Alhaddad M, et al. Red deer umbilical cord lining mesenchymal stem cell extract cream for rejuvenation of the face. Journal of Drugs in Dermatology, 2019. Link
- StemFinder review of first-hand patient accounts on Reddit and patient forums, 2026. Method
- Estupiñan B, et al. Adipose mesenchymal stem cell-derived exosomes versus platelet-rich plasma for photoaged facial skin: an investigator-blinded, split-face trial. Journal of Cosmetic Dermatology, 2025. Link
- Chien WY, et al. Stem cell-derived conditioned medium for alopecia: a systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery, 2024. Link
- Park KY, et al. Adverse reactions following intradermal injection of exosome-based formulations: a case series. Journal of Cosmetic Dermatology, 2025. Link
- AlBargawi S, et al. Necrosis following dermal injection of lyophilized exosomes: a case report. Journal of Cosmetic Dermatology, 2025. Link
- Zhuang J, et al. Treatment of anaphylaxis after injection of stem cell exosomes. Journal of Craniofacial Surgery, 2023. Link
- National Pharmaceutical Regulatory Agency. Guidelines for registration of cell and gene therapy products in Malaysia, 2nd edition, 2025. Link
- COFEPRIS. La COFEPRIS suspendió clínica del D.F. que ofrecía tratamientos con células madre sin aval científico, 2015. Link







